Merck and CEPI Launch $30 Million Initiative to Develop More Affordable Ebola Vaccine for Low-Income Countries
核心洞察
Merck (搜索) has partnered with the Coalition for Epidemic Preparedness Innovations (搜索) (CEPI) on a $30 million program to develop an updated version of its WHO-prequalified Ebola (搜索) vaccine, Ervebo, aimed at improving affordability and access for low- and middle-income countries.
The collaboration will focus on optimizing Ervebo's complex and expensive manufacturing process to increase yield, extend shelf life, and enable storage in standard refrigerators for several months.
Merck (搜索) will work with Hilleman Laboratories (搜索) on vaccine development and explore options to supply public-sector buyers in target countries at significantly reduced prices compared to the current vaccine.
Merck (搜索) and the Coalition for Epidemic Preparedness Innovations (搜索) (CEPI) announced on Wednesday a $30 million partnership to develop an updated version of the pharmaceutical giant's Ebola (搜索) vaccine, targeting improved affordability and accessibility for low- and middle-income countries.
The collaboration centers on enhancing the manufacturing process for Merck (搜索)'s WHO-prequalified Ebola (搜索) vaccine, Ervebo, with the goal of increasing production yield and extending shelf life. According to CEPI, Ervebo's current production process is complex, making it expensive and difficult to manufacture at scale.
Manufacturing Process Improvements
The planned improvements are expected to significantly reduce costs and allow the vaccine to be stored in standard refrigerators for several months, addressing key logistical challenges in resource-limited settings. This represents a substantial advancement from the current storage requirements, which present barriers to widespread deployment in regions most vulnerable to Ebola (搜索) outbreaks.
Partnership Structure and Development
Under the collaboration agreement, Merck (搜索) will work directly with Hilleman Laboratories (搜索) on development of the updated vaccine formulation. The partnership also includes plans to explore supply options for public-sector buyers in low- and middle-income countries at significantly lower prices than the current vaccine.
CEPI's funding will specifically support Hilleman Laboratories (搜索)' clinical development work, while SK bioscience (搜索) and IDT Biologika (搜索) will focus on developing the updated drug-substance process and related drug product manufacturing.
Global Health Impact
The initiative addresses a critical gap in global health preparedness by targeting the cost and accessibility barriers that have historically limited Ebola (搜索) vaccine deployment in the regions most at risk. Ervebo, which already holds WHO prequalification status, has demonstrated efficacy in preventing Ebola virus disease, but its complex manufacturing requirements have posed challenges for widespread implementation.
The collaboration represents a significant investment in epidemic preparedness infrastructure, particularly for countries that have been disproportionately affected by Ebola (搜索) outbreaks but lack the resources to access vaccines at current pricing levels.